Dr. Carolina Barillas-Mury Elected into the NAM
NIH inventor Carolina Barillas-Mury, M.D., Ph.D., has been elected into the National Academy of Medicine (NAM) this year. The NAM is made up of over 2,000 elected members from around the globe who give scientific and policy guidance relating to human health. This honor is one of the highest that can be bestowed upon an individual in the health and medicine field. It is given to those who have made critical science discoveries and have demonstrated a commitment to public service.
Dr. Barillas-Mury works in the National Institute of Allergy and Infectious Diseases (NIAID) Mosquito Immunity and Vector Competence Section. Her work investigates the interactions between the mosquito immune system and Plasmodium parasites to understand how they affect malaria transmission.
Dr. Barillas-Mury has a technology available for collaboration that’s commercial applications include a malaria vaccine, diagnostic, and therapeutic. P47 allows the parasite to suppress or evade the immune system. This technology is able to disrupt the function of P47 which can control and/or reduce the prevalence of malaria.
The competitive advantages of this technology are:
- It is a single-protein malaria transmission-blocking vaccine.
- It is cost-effective and has a simple manufacturing process for a vaccine.
- It is a potentially lower-cost malarial vaccine for developing/developed countries.
If you are interested in reading more about this technology or are interested in collaboration, please click here.